Why the Correction Spells Opportunity for Solar Investors (SEDG, JKS, ARRY, SUNW, CSIQ, GSFI)

It’s not new – solar stocks take a beating when we run into macro market bearish events that don’t also drive interest rates into the floor. Monday was another such case – Evergrande, the Chinese property company with over $300 billion in liabilities looks set to default. Markets often struggle toward the end of calendar […]

What Trillions in Green Infrastructure Spending Means for Solar Stocks (GSFI, ARRY, FSLR, SEDG)

The “good news” for solar investors looking to put cash to work is that solar stocks have underperformed the major averages so far this year. That’s good news because the fundamental picture for the group may be better than ever after profit-taking activity and supply chain obstacles have keep multiples contained right into the teeth […]

Solar Stocks in Focus: Consolidation Spells Opportunity (CSIQ, SEDG, GSFI, SOL, SPWR, RUN, ARRY, JKS)

Solar energy stocks have been consolidating over recent months, potentially providing a value opportunity for market participants looking to allocate new capital to names like Canadian Solar Inc. (NASDAQ:CSIQ), Solaredge Technologies Inc (NASDAQ:SEDG), Green Stream Holdings Inc (OTC US:GSFI), ReneSola Ltd. (NYSE:SOL), SunPower Corporation (NASDAQ:SPWR), Sunrun Inc (NASDAQ:RUN), Array Technologies Inc (NASDAQ:ARRY), and JinkoSolar Holding […]

Key Stocks to Watch in the Solar Space (GSFI, FSLR, SPWR, ARRY, CSIQ, ENPH, TAN)

The future of the energy industry is likely going to be a hodgepodge of different renewable sources. But the primary factor will be solar power.  The solar industry is a prime example of a set-it-and-forget-it secular growth theme that – while featuring occasional bouts of volatility and the need for internal stock picking – will […]

Array Biopharma Inc (NASDAQ:ARRY)’s Board of Directors Brings on board Shalini Sharp

Array Biopharma Inc (NASDAQ:ARRY) has today come forward to announce that Shalini Sharp, the Chief Financial Officer who is at the same time Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)’s Executive Vice President move to work with the provider’s Board of Directors. This happened in April 27, 2017 and according to close sources, the entry spells a lot […]